MPWT
IPXL

MassMutual Private Wealth & Trust’s Impax Laboratories, Inc. IPXL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-44
Closed -$1.16K – 636
2014
Q1 		$1.16K Buy
+44
New +$1.1K ﹤0.01% 553

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

MassMutual Private Wealth & Trust's IPXL Position: Q2 2014 in Review

MassMutual Private Wealth & Trust sold out of Impax Laboratories, Inc. (IPXL) in Q2 2014, closing a stake of 44 shares — an estimated $1.16K sold.

MassMutual Private Wealth & Trust first reported a position in IPXL in Q1 2014 and held it in 1 quarter. The position peaked at $1.16K in Q1 2014. 185 funds tracked by Wall St. Rank hold IPXL as of Q2 2014.

  • MassMutual Private Wealth & Trust reported no remaining Impax Laboratories, Inc. position as of Q2 2014 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 44 Impax Laboratories, Inc. shares in Q2 2014, an estimated $1.16K.
  • MassMutual Private Wealth & Trust first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Impax Laboratories, Inc. position peaked at $1.16K in Q1 2014.
  • 185 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2014.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2014, filed 9 Jul 2014.